The biopharmaceutical company Arbutus Biopharma Corporation (ABUS), a subsidiary of Roivant Sciences Ltd. (ROIV), is currently actively evaluating a capital return plan.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The plan aims to return capital to the company's shareholders in the third quarter of the 2026 calendar year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
EUR/GBP Price Forecast: Rejection at 0.8500 leaves yearly low at 0.8455 exposed
FXStreet•2026/10/07 07:54
Dalio issues another warning: AI is a “classic bubble,” and the tipping point of the bubble is “very close.”
Dalio warns that artificial intelligence is in a "classic bubble," as rising interest rates combined with liquidity demands are pushing it close to the breaking point; he states, "We are already very close to that point."
智通财经•2026/10/07 07:43
A cryptocurrency exchange is considering launching tokenized stocks.
AiCoin•2026/10/07 07:37
Crypto prices
More
Bitcoin
BTC
$84,037.16
-2.00%
Ethereum
ETH
$2,615.38
-3.50%
Tether USDt
USDT
$0.9997
-0.01%
BNB
BNB
$773.11
-0.96%
XRP
XRP
$1.47
-2.28%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$118.55
-1.60%
TRON
TRX
$0.3332
-1.01%
Hyperliquid
HYPE
$90.89
-2.36%
Zcash
ZEC
$1,323.86
-1.20%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now